Implantica AG engages in the provision of effective care for serious health conditions and improving patient quality of life by bringing advanced technology into the body. Its product RefluxStop, is a passive CE-marked implant for prevention of gastroesophageal reflux. The company was founded by Peter Forsell in 2015 and is headquartered in Vaduz, Liechtenstein.
Die Digitalisierung ist im Gesundheitswesen angekommen. Nicht umsonst ist der Bereich Electronic Health (eHealth) inzwischen der am schnellsten wachsende Behandlungsbereich der Welt.
Implantica AG (publ.), a medtech company at the forefront of introducing advanced technology into the body, is pleased to report an impressive level of support from a large...
Implantica AG (publ.), a medtech company at the forefront of introducing advanced technology into the body, including a unique device RefluxStop™ for the treatment of acid...
Implantica AG (publ.), a medtech company at the forefront of introducing advanced technology into the body, announces another key milestone with an independent study demonstrating...
Implantica AG (publ.), a medtech company at the forefront of introducing advanced technology into the body, announces the independent study “Multicentric short term and...
Vergleichen Sie Implantica AG SDR´s mit ähnlichen Unternehmen im Healthcare Sektor.
Wir finden für unsere Leser softwaregestützt die besten Aktien der Welt und schreiben darüber, wie man diese handeln muss, um Geld zu verdienen.
Implantica AG SDR´s Aktie